GL1X · GenesisL1 explorer

Research workbench

Back pocket flexibility provides group-II pak selectivity for type 1 kinase inhibitors

Analyse Back pocket flexibility provides group-II pak selectivity for type 1 kinase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4O0Y
Type
protein
Length
291 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase pak 4
EC
2.7.11.1
UniProt
O96013
Ligands
2OO
Pockets
3 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase pak 4 (EC 2.7.11.1)protein29141% helix, 18% strandO96013

Ligands and binding sites

  • 2OO · 4-[1-(4-amino-1,3,5-triazin-2-yl)-2-(ethylamino)-1H-benzimidazol-6-yl]-2-methylbut-3-yn-2-ol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12000.610.81292OO
2550.410.8216empty
3590.380.8016empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 4O0Y · Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • O96013 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase pak 4 (O96013) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.